Molecular and Structural Studies of Antibody Diversity Mechanisms
抗体多样性机制的分子和结构研究
基本信息
- 批准号:10242126
- 负责人:
- 金额:$ 39.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-30 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:Active SitesAmino AcidsAntibodiesAntibody DiversityAntibody FormationAntibody RepertoireAntigen TargetingAntigensAreaBindingBiochemicalBiologicalBiological Response ModifiersCattleCellsCellular AssayColorComplementarity Determining RegionsComplexCysteineDataDiagnosticDiagnostics ResearchDisulfidesElectron MicroscopyEnzyme ActivationEnzymesEpitopesEventFab ImmunoglobulinsFamilyFlow CytometryGene MutationGenesGeneticGenetic StructuresHIVHIV AntibodiesHIV-1HumanImmune responseImmunizationImmunizeImmunoglobulin GImmunoglobulin Somatic HypermutationIn VitroInfectious AgentInvestigational TherapiesIon ChannelLabelLeftLengthLightMapsMatrix MetalloproteinasesMediatingMedicineMetalloproteasesMethodsModelingMolecularMolecular GeneticsMolecular StructureMusMutagenesisMutateMutationPathway interactionsPatternPlayPolysaccharidesProcessPropertyProteinsReagentRecombinantsRoleSite-Directed MutagenesisStructureSurfaceSystemTertiary Protein StructureTestingTherapeuticTimeV(D)J RecombinationVaccine DesignVaccinesVertebratesViralVirusactivation-induced cytidine deaminaseantibody engineeringantigen bindingantigen challengebasecombinatorialdisulfide bondelectron crystallographyin vivoinsightknob proteinneutralizing antibodynovelresponsetherapeutic candidatevaccine response
项目摘要
Abstract
Antibodies are extremely important as the primary mediators of the immune response to
infectious agents and vaccines, but also as recombinant molecules used as therapeutics,
diagnostics, and research reagents. Thus, understanding the mechanisms by which antibodies
form, bind, and neutralize their targets is very important in multiple biomedical areas. Most
vertebrate antibody repertoires form their diversity through V(D)J recombination, where
combinatorial rearrangement of V, D, and J genes form a vast repertoire where the
complementarity determining regions (CDRs) form a relatively flat binding surface for interaction
with antigen. Remarkably, cows appear to have a different mechanism for generating diversity
and binding antigen; cow antibodies have particularly long CDR H3 regions, a subset of which
can be over 70 amino acids long, which form -ribbon “stalk” and disulfide-bonded “knob”
minidomains that protrude far from the typical antibody surface. Remarkably, antibodies from
this repertoire can potently and broadly neutralize HIV, whereas normal human or mouse
antibody repertoires cannot. Therefore, they have unique abilities to bind and neutralize
particularly challenging antigens. Here we propose studies to understand in molecular detail the
genetic mechanisms underlying formation of these antibodies, the binding properties of the stalk
and knob minidomains, and the unique potential of these antibodes to bind bivalently and
bispecifically. These studies will provide insight into mechanisms of viral neutralization
generally, and particularly HIV neutralization. Additionally, given the potential of these
antibodies to bind recessed epitopes, we will generate additional antibodies against particularly
challenging antigens like enzymatic active sites and ion channels. We will employ mutagenesis,
binding, and structural methods, as well as cellular assays to evaluate the unique properties of
these antibodies. Understanding this novel class of antibodies in detail could provide
fundamental insights needed for effective vaccine design as well as discovery and engineering
of antibodies against some of the most challenging targets in biomedicine. Similarly, our unique
antibodies discovered and characterized in this proposal could eventually become therapeutic
candidates themselves.
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Milking the Cow: Cattle-Derived Chimeric Ultralong CDR-H3 Antibodies and Their Engineered CDR-H3-Only Knobbody Counterparts Targeting Epidermal Growth Factor Receptor Elicit Potent NK Cell-Mediated Cytotoxicity.
- DOI:10.3389/fimmu.2021.742418
- 发表时间:2021
- 期刊:
- 影响因子:7.3
- 作者:Pekar L;Klewinghaus D;Arras P;Carrara SC;Harwardt J;Krah S;Yanakieva D;Toleikis L;Smider VV;Kolmar H;Zielonka S
- 通讯作者:Zielonka S
Rapid elicitation of broadly neutralizing antibodies to HIV by immunization in cows.
- DOI:10.1038/nature23301
- 发表时间:2017-08-03
- 期刊:
- 影响因子:64.8
- 作者:Sok D;Le KM;Vadnais M;Saye-Francisco KL;Jardine JG;Torres JL;Berndsen ZT;Kong L;Stanfield R;Ruiz J;Ramos A;Liang CH;Chen PL;Criscitiello MF;Mwangi W;Wilson IA;Ward AB;Smider VV;Burton DR
- 通讯作者:Burton DR
Germline-Encoded Positional Cysteine Polymorphisms Enhance Diversity in Antibody Ultralong CDR H3 Regions.
- DOI:10.4049/jimmunol.2200455
- 发表时间:2022-12-01
- 期刊:
- 影响因子:4.4
- 作者:Jenkins, Gabrielle Warner;Safonova, Yana;V. Smider, Vaughn
- 通讯作者:V. Smider, Vaughn
Evolution of immunogenetic components encoding ultralong CDR H3.
- DOI:10.1007/s00251-023-01305-9
- 发表时间:2023-08
- 期刊:
- 影响因子:3.2
- 作者:Ott, Jeannine A. A.;Mitchell, Christian;Sheppard, Morgan;Deiss, Thad C. C.;Horton, J. M. Cody;Haakenson, Jeremy K. K.;Huang, Ruiqi;Kelley, Abigail R. R.;Davis, Brian W. W.;Derr, James N. N.;Smider, Vaughn V. V.;Criscitiello, Michael F. F.
- 通讯作者:Criscitiello, Michael F. F.
Bos taurus ultralong CDR H3 antibodies.
- DOI:10.1016/j.sbi.2016.05.004
- 发表时间:2016-06
- 期刊:
- 影响因子:6.8
- 作者:Vadnais ML;Smider VV
- 通讯作者:Smider VV
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vaughn Vasil Smider其他文献
Vaughn Vasil Smider的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vaughn Vasil Smider', 18)}}的其他基金
Broadly neutralizing SARS-CoV-2 peptidic knobs
广泛中和 SARS-CoV-2 肽旋钮
- 批准号:
10735902 - 财政年份:2023
- 资助金额:
$ 39.94万 - 项目类别:
Ultralong CDR3 antibodies targeting exhausted T cells
针对耗尽 T 细胞的超长 CDR3 抗体
- 批准号:
9894677 - 财政年份:2020
- 资助金额:
$ 39.94万 - 项目类别:
Defining clinically relevant viral epitopes with cow antibodies
用牛抗体定义临床相关的病毒表位
- 批准号:
9360293 - 财政年份:2017
- 资助金额:
$ 39.94万 - 项目类别:
Defining clinically relevant viral epitopes with cow antibodies
用牛抗体定义临床相关的病毒表位
- 批准号:
10014637 - 财政年份:2017
- 资助金额:
$ 39.94万 - 项目类别:
Defining clinically relevant viral epitopes with cow antibodies
用牛抗体定义临床相关的病毒表位
- 批准号:
10202672 - 财政年份:2017
- 资助金额:
$ 39.94万 - 项目类别:
Cow ultralong CDR3 antibodies targeting HIV gp120
靶向 HIV gp120 的牛超长 CDR3 抗体
- 批准号:
9141521 - 财政年份:2016
- 资助金额:
$ 39.94万 - 项目类别:
Molecular and Structural Studies of Antibody Diversity Mechanisms
抗体多样性机制的分子和结构研究
- 批准号:
9868578 - 财政年份:2014
- 资助金额:
$ 39.94万 - 项目类别:
Molecular and Structural Studies of Antibody Diversity Mechanisms
抗体多样性机制的分子和结构研究
- 批准号:
9319776 - 财政年份:2014
- 资助金额:
$ 39.94万 - 项目类别:
Molecular and Structural Studies of Antibody Diversity Mechanisms
抗体多样性机制的分子和结构研究
- 批准号:
9982985 - 财政年份:2014
- 资助金额:
$ 39.94万 - 项目类别:
相似国自然基金
PEDV变异株逃逸经典株中和抗体关键氨基酸位点的解析
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PEDV变异株逃逸经典株中和抗体关键氨基酸位点的解析
- 批准号:32202823
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
聚氨基酸用于蛋白质翻译后修饰泛抗体的诱导与制备
- 批准号:22105008
- 批准年份:2021
- 资助金额:20 万元
- 项目类别:青年科学基金项目
基于非天然氨基酸光交联的表位靶向抗体筛选及其应用研究
- 批准号:
- 批准年份:2020
- 资助金额:58 万元
- 项目类别:面上项目
磷酸化组氨酸(pHis)的抗体富集、质谱鉴定及生物功能研究
- 批准号:91953103
- 批准年份:2019
- 资助金额:60.0 万元
- 项目类别:重大研究计划
相似海外基金
Accelerated development of advanced leads against SARS-CoV-2 and other pandemic viruses
加速开发针对 SARS-CoV-2 和其他大流行病毒的先进先导药物
- 批准号:
10513922 - 财政年份:2022
- 资助金额:
$ 39.94万 - 项目类别:
Development of a suite of high-specificity fucose binding reagents
一套高特异性岩藻糖结合试剂的开发
- 批准号:
10084298 - 财政年份:2020
- 资助金额:
$ 39.94万 - 项目类别:
Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa
撒哈拉以南非洲 VRC01 抗体介导的预防 2b 期试验中 HIV-1 突破性感染的抗原和病毒学特征
- 批准号:
10609096 - 财政年份:2020
- 资助金额:
$ 39.94万 - 项目类别:
Development of a suite of high-specificity fucose binding reagents
一套高特异性岩藻糖结合试剂的开发
- 批准号:
9909159 - 财政年份:2020
- 资助金额:
$ 39.94万 - 项目类别:
Universal epitopes-based recombinant influenza vaccines
基于通用表位的重组流感疫苗
- 批准号:
10092937 - 财政年份:2020
- 资助金额:
$ 39.94万 - 项目类别: